Ehrlich Christopher B 4
4 · CERO THERAPEUTICS HOLDINGS, INC. · Filed Jan 9, 2026
Insider Transaction Report
Form 4
Ehrlich Christopher B
DirectorChairman and CEO
Transactions
- Award
Stock Option (Right to Buy)
2026-01-07+4,530,997→ 4,530,997 totalExercise: $0.06From: 2026-01-07Exp: 2036-01-06→ Common Stock (4,530,997 underlying)